Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 22.22
    Last
  • 0.31  -1.38%
    Today's Change
  • 22.53
    Previous Close
  • Today
     
    9.51
    23.30
    52 Week Low - High
8:10 pm ET 7/29/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding49 million
Market Cap$1 billion
Return on Equity ttm16.24%
Last DividendSUPN:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.337
EPS: Year Est. 12/16 ttm0.634
 
EPS: Quarterly Actual 3/16 0.10
EPS: Quarterly Est. 6/16 0.13
 
Price/Earnings ttm65.87
Relative Price/Earnings3.238
Earnings Growth Rate-36.17
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$144 million
Net Income$14 million
Total Assets$189 million
Employees344
Web Sitewww.supernus.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!